Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma 8Hodgkin Disease 4Lymphoma, Non-Hodgkin 2Recurrence 1Radiation Injuries 1Neurotoxicity Syndromes 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, AIDS-Related 1HIV Infections 1

Interventions

Rituximab 155Cyclophosphamide 120fludarabine phosphate 71Whole-Body Irradiation 55Mycophenolic Acid 54Etoposide 53Peripheral Blood Stem Cell Transplantation 46fludarabine 45Melphalan 44Granulocyte Colony-Stimulating Factor 43Busulfan 43Tacrolimus 39Filgrastim 37Vincristine 33Cyclosporine 31Bendamustine Hydrochloride 31Prednisone 29Doxorubicin 29Antilymphocyte Serum 28Methotrexate 27Cytarabine 27Lenalidomide 23Carmustine 22Bortezomib 22plerixafor 20Dexamethasone 19Thiotepa 17Stem Cell Transplantation 17Radiotherapy 17tositumomab I-131 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Lymphoma, Non-Hodgkin × Procarbazine × Clear all
NCT00596154 2024-04-01

PCNSL

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
33 enrolled 9 charts
Lymphoid

Lymphoma, Non-Hodgkin

NCT00151281 2018-06-28

Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma

Weill Medical College of Cornell University

Phase 2 Completed
25 enrolled 8 charts
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡